Active Ingredient: Brolucizumab; Atc Code Tender - 138108929

Procurement Summary

Country: Germany

Summary: Active Ingredient: Brolucizumab; Atc Code: S01La06; Dosage Form: All; Potency: All; Pack Size: all (Including Hospital Packs, if Prescribed on Sample 16 or Form E16A)

Deadline: 08 Apr 2026

Posting Date: 19 Mar 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 138108929

Document Ref. No.: 0000/0016

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

This announcement serves to conclude drug discount contracts in accordance with Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the active ingredient(s) mentioned under the title. This does not involve the award of public contracts within the meaning of the directive 2014/24/EU or Sections 97 ff GWB. Any pharmaceutical company can become a contractual partner in accordance with Section 4 Paragraph 18 AMG. According to the case law of the European Court of Justice, such approval procedures are not necessarily subject to public procurement law, as due to the lack of selection decision no competition takes place. The announcement serves as an invitation to conclude discount agreements with conditions that apply equally to all contractual partners and are not subject to discretion, including the determination of the discount. The The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the designated contact point. Additional Classification Codes Quantity

Documents

 Tender Notice